Completed PHASE1 INTERVENTIONAL 3-arm NCT03063645

Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

Sponsor: Celerion

Conditions Healthy

Interventions AC-1202 AC-SD-01 (50 g) AC-SD-01 (75 g)

Updated 8 times since 2017 Last updated: Jun 26, 2017 Started: Mar 11, 2017 Primary completion: Apr 7, 2017 Completion: May 5, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. Celerion leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Jun 2019 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jul 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
May 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE1

Status: Not Yet Recruiting → Active Not Recruiting
Mar 2017 — May 2017 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Celerion
Cerecin

Data source: Cerecin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lincoln, United States